Economic Costs of Diabetes in the U.S. in 2007

Cited by (1,001)

Items 701–800 of 1,001

1. Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States
   Won Chan Lee, Christopher Conner, Mette Hammer · 2010 · Clinical Therapeutics
2. Opportunities for Using Lipoprotein Subclass Profile by Nuclear Magnetic Resonance Spectroscopy in Assessing Insulin Resistance and Diabetes Prediction
   Alexis C. Wood, William Timothy Garvey, Tara Dall, Robert Honigberg, Ray Pourfarzib · 2012 · Metabolic Syndrome and Related Disorders
3. Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA)
   Frank Petrak, Martin Hautzinger, Kristin Plack, Kai Kronfeld, Christian Ruckes, Stephan Herpertz, Matthias Johannes Müller · 2010 · BMC Geriatrics
4. Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes
   William J. Valentine, Richard Fulton Pollock, Juliette Plun-Favreau, Jeremy R. White · 2010 · Current Medical Research and Opinion
5. Diabetes Mellitus and Gestational Diabetes Mellitus
   SA Begum, Romena Afroz, Quayuma Khanam, A Khanom, TS Choudhury · 2015 · Journal of Paediatric Surgeons of Bangladesh
6. Medicare Claims Data as Public Use Files
   Erkan Erdem, Holly Korda, Samuel C. Haffer, Cary S. Sennett · 2014 · Journal of Public Health Management and Practice
7. Ankle-brachial index and diabetic neuropathy: study of 225 patients
   Liliana Chevtchouk, Marcio Heitor Stelmo da Silva, Osvaldo J. M. Nascimento · 2017 · Arquivos de Neuro-Psiquiatria
8. Achievable Cost Saving and Cost-Effective Thresholds for Diabetes Prevention Lifestyle Interventions in People Aged 65 Years and Older: A Single-Payer Perspective
   Jennifer M. Anderson · 2012 · Journal of the Academy of Nutrition and Dietetics
9. Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
   Shaker A. Mousa · 2009 · Pharmacogenomics and Personalized Medicine
10. A Spoonful of Sugar Helps the Medicine Go Down: the Relationship Between Food Prices and Medical Expenditures on Diabetes
    Chad D. Meyerhoefer, Ephraim S. Leibtag · 2010 · American Journal of Agricultural Economics
11. Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes
    Caronda J. Moore, Chun Hong Shao, Ryoji Nagai, Shelby Kutty, Jaipaul Singh, Keshore R. Bidasee · 2013 · Molecular and Cellular Biochemistry
12. What Is the Ideal Blood Pressure Goal for Patients with Diabetes Mellitus and Nephropathy?
    Mark L. Lipman, Ernesto L. Schiffrin · 2012 · Current Cardiology Reports
13. Oral hygiene and cardiometabolic disease risk in the survey of the health of W isconsin
    Jeffrey J. VanWormer, Amit Acharya, Robert T. Greenlee, F. Javier Nieto · 2012 · Community Dentistry And Oral Epidemiology
14. Shilianhua extract inhibits GSK-3β and promotes glucose metabolism
    Jun Yin, Aamir R. Zuberi, Zhan‐Guo Gao, Dong Liu, Zhijun Liu, Jianping Ye · 2009 · American Journal of Physiology-Endocrinology and Metabolism
15. Economic burden of cirrhosis in Catalonia: a population-based analysis
    Mireia Miquel, Montserrat Clèries, Mercedes Vergara, Emili Vela · 2018 · BMJ Open
16. Epidemiology of Type 2 Diabetes
    Ronald C.W., Peter C.Y. Tong · 2010 · Wiley eBooks
17. The economic impact of morbid obesity
    Eldo Ermenegildo Frezza, Mitchell Steven Wachtel · 2009 · Surgical Endoscopy
18. Diabetische Neuropathie und diabetischer Fuß (Update 2019)
    Lechleitner, Monika, Abrahamian, Heidemarie, Francesconi, Claudia, Kofler, Markus, Sturm, Wolfgang, Köhler, Gerd · 2019 · Wiener klinische Wochenschrift
19. Real-World Evaluation of the Effects of Counseling and Education in Diabetes Management
    Dalal, Mehul R., Robinson, Scott B., Sullivan, Sean D. · 2014 · Diabetes Spectrum
20. Improving the Efficiency and Effectiveness of Performing the Diabetic Foot Exam
    Theodore A. Praxel, Trina J. Ford, E. Vanderboom · 2011 · American Journal of Medical Quality
21. Analyzing treatment aggressiveness and identifying high‐risk patients in diabetic foot ulcer return to care
    Austin C. Remington, Tina Hernandez‐Boussard, Nicholus M. Warstadt, Micaela A. Finnegan, Robyn K. Shaffer, Jereen Z. Kwong, Catherine Mills Curtin · 2016 · Wound Repair and Regeneration
22. Changes in Direct Medical Cost and Medications for Managing Diabetes in Beijing, China, 2016 to 2018: Electronic Insurance Data Analysis
    Lixin Guo, Jie Zheng, Qi Pan, Qun Zhang, Yan Zhou, Weihao Wang, Lina Zhang, Solomon Hailemariam Tesfaye, Jie Zhang · 2021 · The Annals of Family Medicine
23. The Cost of Control: Cost-effectiveness Analysis of Hybrid Closed-Loop Therapy in Youth
    Anthony Pease, Emily Joy Callander, Ella Zomer, Mary Binsu Abraham, Elizabeth Ann Davis, Timothy William Jones, Danny Liew, Sophia Zoungas · 2022 · Diabetes Care
24. The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Improve Diabetes Treatment and Reduce Complications
    M. Carol Greenlee, Shari Danielle Bolen, William H Chong, Ayotunde O. Dokun, Jasmine D. Gonzalvo, Meredith A. Hawkins, William H. Herman, Ellen Leake, Barbara L. Linder, Paul R. Conlin · 2023 · Diabetes Care
25. Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study
    Juan Ybarra, Jeroni Jurado, Maria García-Gil, Edurne Zabaleta‐del‐Olmo, Teresa Mir-Coll, Adelaida Zabalegui, Josép Vidal, June Hart Romeo · 2014 · European Journal of Cardiovascular Nursing
26. Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus
    Uche Anadu Ndefo, Okwuchukwu Okoli, Goldina Ikezuagu Erowele · 2013 · American Journal of Health-System Pharmacy
27. Using Insulin Pump Therapy in Poorly Controlled Type 2 Diabetes
    Phyllis Wolff-McDonagh, Judith A. Kaufmann, Stephen Earl Foreman, Steven Wisotsky, Jo Ann Wisotsky, Craig Wexler · 2010 · The Science of Diabetes Self-Management and Care
28. Assessing the impact of diabetes-related comorbidities and care on the hospitalization costs for patients with diabetes mellitus in Japan
    Dulamsuren Lkhagva, Kazuaki Kuwabara, Shinya Matsuda, Yan Gao, Akira Babazono · 2012 · Journal of Diabetes and its Complications
29. Counting the Cost of Diabetes in the Solomon Islands and Nauru
    Si Thu Win Tin, George Iro, Eva Gadabu, Ruth Colagiuri · 2015 · PLoS ONE
30. Can Chronic Disease Management Programs for Patients with Type 2 Diabetes Reduce Productivity-Related Indirect Costs of the Disease? Evidence from a Randomized Controlled Trial
    Omolola E. Adepoju, Jane Nelson Bolin, Robert L. Ohsfeldt, Charles David Phillips, Hongwei Zhao, Marcia G. Ory, Samuel Nana Forjuoh · 2013 · Population Health Management
31. Modeling the Physiological Factors Affecting Glucose Sensor Function in Vivo
    Matthew T. Novak, William Matthew Reichert · 2015 · Journal of Diabetes Science and Technology
32. Overview of Tissue Engineering Concepts and Applications
    Debanjan Sarkar, Weian Zhao, Sebastian Schaefer, James A. Ankrum, Grace Sock Leng Teo, Maria Nunes Pereira, Lino Ferreira, Jeffrey M. Karp · 2012 · Elsevier eBooks
33. Achieving Cardiovascular Health
    Dariush Mozaffarian · 2011 · Journal of the American College of Cardiology
34. A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine
    Derek A. Misurski, Maureen J. Lage, Rosalind P. Fabunmi, Kristina Secnik Boye · 2009 · Applied Health Economics and Health Policy
35. Trends in recorded capillary blood glucose and hypoglycaemia in hospitalised patients with diabetes
    Gregory C. Jones, Heather M. Casey, Colin Graham Perry, Brian Kennon, Christopher A. R. Sainsbury · 2014 · Diabetes Research and Clinical Practice
36. SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
    Elamin Abdelgadir, Fouzia Rashid, Alaaeldin M. Bashier, Razan Ali · 2018 · Journal of Clinical Medicine Research
37. Illness representations, emotional distress, coping strategies, and coping efficacy as predictors of patient outcomes in type 2 diabetes
    Patricia L. Hart, Cecelia Gatson Grindel · 2010 · Journal of Nursing and Healthcare of Chronic Illness
38. Effectiveness and cost-effectiveness of knowledge transfer and behavior modification interventions in type 2 diabetes mellitus patients—the INDICA study: a cluster randomized controlled trial
    Yolanda Ramallo‐Fariña, Lidia García‐Pérez, Iván Castilla‐Rodríguez, Lilisbeth Perestelo‐Pérez, Ana María Wägner, Pedro Luis de Pablos-Velasco, Armando Carrillo Domínguez, Mauro Boronat Cortés, Laura Vallejo‐Torres, Marcos Estupiñán Ramírez et al. · 2015 · Implementation Science
39. Impact of Mental Health Visits on Healthcare Cost in Patients with Diabetes and Comorbid Mental Health Disorders
    Leonard E. Egede, Mulugeta Gebregziabher, Yumin Zhao, Clara Elizabeth Dismuke, Rebekah J. Walker, Kelly J. Hunt, Robert Neal Axon · 2014 · PLoS ONE
40. MRI of the cuboid bone: Analysis of changes in diabetic versus non-diabetic patients and their clinical significance
    Claude Pierre-Jerome, Emmanuel Reyes, Valeria M. Moncayo, Zhengjia Nelson Chen, Michael R. Terk · 2011 · European Journal of Radiology
41. Point-of-care diagnostics – is this driven by supply or demand?
    David Huckle · 2010 · Expert Opinion on Medical Diagnostics
42. National Trends over One Decade in Hospitalization for Acute Myocardial Infarction among Spanish Adults with Type 2 Diabetes: Cumulative Incidence, Outcomes and Use of Percutaneous Coronary Intervention
    Ana López‐de‐Andrés, Rodrigo Jiménez‐García, Valentín Hernández‐Barrera, Isabel Jiménez‐Trujillo, Carmen Gallardo-Pino, Ángel Gil de Miguel, Pilar Carrasco‐Garrido · 2014 · PLoS ONE
43. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database
    Karen L. Rascati, Katherine Richards, Debra A. Lopez, Long Cheng, James P. Wilson · 2013 · Diabetes Obesity and Metabolism
44. Documento de consenso sobre el tratamiento al alta hospitalaria del paciente con hiperglucemia
    Antonio Pérez, Ricardo Gómez‐Huelgas, Fernando Álvarez Guisasola, Javier García Alegría, José Javier Mediavilla Bravo, Edelmiro Luis Menéndez Torre · 2012 · Medicina Clínica
45. Hypoglycemic effects and mechanisms of electroacupuncture on insulin resistance
    Jieyun Yin, Jian Kuang, Manisha Chandalia, Demidmaa Tuvdendorj, Batbayar Tumurbaatar, Nicola I. Abate, Jiande D. Z. Chen · 2014 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
46. Diabetes Education in the Hospital: Establishing Professional Competency
    Carol S. Manchester · 2008 · Diabetes Spectrum
47. Current outcomes in islet versus solid organ pancreas transplant for β-cell replacement in type 1 diabetes
    Steven A. Wisel, Hillary J. Braun, Peter G. Stock · 2016 · Current Opinion in Organ Transplantation
48. Factors of occurrence and improvement methods of presenteeism attributed to diabetes: A systematic review
    Koji Mori, Takahiro Mori, Tomohisa Nagata, Masako Nagata, Mahoko Iwasaki, Hiroki Sakai, Koki Kimura, Natsumi Shinzato · 2019 · Journal of Occupational Health
49. Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients
    Adane Tesfaye, Haileyesus Josef, Temesgen Bizuayehu Wube, Zeleke Girma, Belay Negasa, Temesgen Muche, Bewunetu Zewude · 2020 · Diabetes Metabolic Syndrome and Obesity
50. Health care providers’ perspective on using family history in the prevention of type 2 diabetes: a qualitative study including different disciplines
    Suzanne C. M. van Esch, Wieke H Heideman, Wilmy Cleijne, Martina Cornelia Cornel, Frank Jan Snoek · 2013 · BMC Family Practice
51. The effect of MTHFR C677T polymorphism on type 2 diabetes mellitus with vascular complications in Chinese Han population: A meta-analysis
    Dan Zhang, Yijun Zhou, Lingling Han, JI Hong-mei, Jia Li · 2014 · Endocrine Journal
52. Age-Corrected Beta Cell Mass Following Onset of Type 1 Diabetes Mellitus Correlates with Plasma C-Peptide in Humans
    David J. Klinke · 2011 · PLoS ONE
53. The Business Case for a Diabetes Self-Management Intervention in a Community General Hospital
    Ashley Micklethwaite, Carol A. Brownson, Mary L. O'Toole, Kerry E. Kilpatrick · 2012 · Population Health Management
54. Relationship between health care insurance status, social determinants and prevalence of diabetes-related microvascular complications in patients with type 1 diabetes: a nationwide survey in Brazil
    Marília Brito Gomes, Deborah Conte Santos, Marcela Pizarro, Laura Gomes Nunes Melo, Bianca Senger Vasconcelos Barros, Renan Magalhães Montenegro, Virgínia Oliveira Fernandes, Carlos Antônio Negrato · 2019 · Acta Diabetologica
55. Overview of type 2 diabetes in Hispanic Americans.
    Ihuoma Okezie Chukwueke, Zaida Cordero‐MacIntyre · 2010 · PubMed
56. Impact of state mandatory insurance coverage on the use of diabetes preventive care
    Rui Li, Ping Zhang, Lawrence E Barker, DeKeely Hartsfield · 2010 · BMC Health Services Research
57. Annotated chromosome maps for renal disease
    Amy Jayne McKnight, Donal J. O'Donoghue, Alexander Peter Maxwell · 2008 · Human Mutation
58. Clustering of unhealthy lifestyle behaviors is associated with nonadherence to clinical preventive recommendations among adults with diabetes
    Rodrigo Jiménez‐García, Jesús Esteban‐Hernández, Valentín Hernández‐Barrera, Isabel Jiménez‐Trujillo, Ana López‐de‐Andrés, Pilar Carrasco‐Garrido · 2010 · Journal of Diabetes and its Complications
59. Barriers to self-care and their association with poor adherence to self-care behaviours in people with type 2 diabetes in Ghana: A cross sectional study
    Victor Mogre, Natalie Johnson, Flora Tzelepis, Alix Edna Hall, Christine Louise Paul · 2020 · Obesity Medicine
60. Knowledge, attitude, and practice of type 2 diabetic patients toward Diabetes Miletus and its cardiovascular complications in Alahsa
    Eman El Sheikh, Jawaher Abdulmonem Alkhars, Afnan Alsaad, Fatimah Albattat, Zainab Al-Omran, Huda Alradhi, Sajeda Almishal, Maryam Alsultan · 2021 · International Journal of Medicine in Developing Countries
61. Retirement due to disabilities in patients with type 1 diabetes a nationwide multicenter survey in Brazil
    On behalf of the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG), Marília Brito Gomes, Carlos Antônio Negrato · 2015 · BMC Public Health
62. Effect of an educational intervention in primary care physicians on the compliance of indicators of good clinical practice in the treatment of type 2 diabetes mellitus [OBTEDIGA project]
    José I. Vidal-Pardo, Teresa R. Pérez-Castro, X. L. López-Álvarez, María Isolina Santiago-Pérez, Francisco Javier García Soidán, Javier Muñiz · 2013 · International Journal of Clinical Practice
63. Attained education and self-assessed health later in life when diagnosed with diabetes in childhood: a population-based study
    Anne Wennick, Inger Hallström, Björn Lindgren, Kristian Bolin · 2011 · Pediatric Diabetes
64. Excess burden of type 1 and type 2 diabetes due to psychopathology
    Evan EA Atlantis · 2012 · Journal of Affective Disorders
65. Associations of cardiorespiratory fitness and parental history of diabetes with risk of type 2 diabetes
    Kara Goodrich, Shannon K. Crowley, Duck-chul Lee, Xuemei Sui, Steven P. Hooker, Steven N. Blair · 2011 · Diabetes Research and Clinical Practice
66. Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review
    Efstratios Moralidis, Triantafyllos Didangelos, Georgios A. Arsos, Vasilios Gabriel Athyros, Dimitri P. Mikhailidis · 2010 · Diabetes/Metabolism Research and Reviews
67. The Biopsychosocial Milieu of Type 2 Diabetes: An Exploratory Study of the Impact of Social Relationships on a Chronic Inflammatory Disease
    Michael M. Olson, Dorothy B. Trevino, Jamal Islam, Larry A. Denner · 2010 · The International Journal of Psychiatry in Medicine
68. Do endometrial natural killer and regulatory T cells differ in infertile and clinical pregnancy patients? An analysis in patients undergoing frozen embryo transfer cycles
    May‐Tal Sauerbrun‐Cutler, Warren J. Huber, Paula M. Krueger, C. James Sung, Phinnara Has, Surendra Sharma · 2021 · American Journal of Reproductive Immunology
69. A critical review on nanomaterial based therapeutics for diabetic wound healing
    Swati Sucharita Singh, Susanta Kumar Behera, Suchita Rai, Suraj Kumar Tripathy, Sankha Chakrabortty, Amrita Mishra · 2022 · Biotechnology and Genetic Engineering Reviews
70. Cost of informal care for diabetic patients in Thailand
    Susmita Chatterjee, Arthorn Riewpaiboon, Piyanuch Piyauthakit, Wachara Riewpaiboon · 2011 · Primary care diabetes
71. Preventing Diabetes in Primary Care: A Feasibility Cluster Randomized Trial
    Diana Dawes, Maureen C. Ashe, Kristin L. Campbell, Douglas Cave, C. Raina Elley, Janusz A. Kaczorowski, PARMJIT S. SOHAL, Ehud Ur, Martin G. Dawes · 2014 · Canadian Journal of Diabetes
72. Direct Health Care Costs of Patients With Type 2 Diabetes Within a Privately Insured Employed Population, 2000 and 2005
    Emily Durden, Berhanu Alemayehu, Jonathan R. Bouchard, Bong Chul Chu, Mark Aagren · 2009 · Journal of Occupational and Environmental Medicine
73. Health Care Utilization and Costs in Type 2 Diabetes Mellitus and Their Association with Renal Impairment
    James Francis Burke, Birgit Kovacs, Leigh Borton, Stephen D. Sander · 2012 · Postgraduate Medicine
74. Incidence of Type 2 Diabetes in Pre-Diabetic Japanese Individuals Categorized by HbA1c Levels: A Historical Cohort Study
    Tetsuya Kawahara, Ryuichiro Imawatari, Chie Kawahara, Tetsuya Inazu, Gen Suzuki · 2015 · PLoS ONE
75. Implementation of the YMCA Diabetes Prevention Program throughout an Integrated Health System: A Translational Study
    Ron Adams, Christopher J. Hebert, Linda McVey, Roger Williams · 2016 · The Permanente Journal
76. Dietary associations with prediabetic states—The DR's EXTRA Study (ISRCTN45977199)
    Harri M. Heikkilä, Ursula Schwab, Benno Krachler, Reija Männikkö, Rainer Rauramaa · 2012 · European Journal of Clinical Nutrition
77. Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin
    Carrie McAdam‐Marx, Junhua Yu, Jonathan R. Bouchard, Mark Aagren, Diana I Brixner · 2009 · Current Medical Research and Opinion
78. Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men
    Atoosa Rabiee, Andrew A. Dwyer, Lisa M. Caronia, Frances J. Hayes, Maria A. Yialamas, Dana K. Andersen, Bijoy J. Thomas, Martin Torriani, Dariush Elahi · 2010 · Endocrine Research
79. Approaches to Treatment of Pre-Diabetes and Obesity and Promising New Approaches to Type 2 Diabetes
    Zachary T. Bloomgarden · 2008 · Diabetes Care
80. The economics of diabetes care: a global perspective
    Rhys Williams · 2015
81. Utilizing Information Technologies for Lifelong Monitoring in Diabetes Patients
    Davide Capozzi, Giordano Lanzola · 2011 · Journal of Diabetes Science and Technology
82. Systematic Review of Therapies for Stable Coronary Artery Disease in Diabetic Patients
    Suvitesh Luthra, Miguel M. Leiva‐Juárez, David Paul Taggart · 2015 · The Annals of Thoracic Surgery
83. Insulin degludec: a novel ultra-long-acting basal insulin for use in Type 1 and 2 diabetes
    Luigi Meneghini, Bresta Miranda-Palma · 2011 · Expert Review of Endocrinology & Metabolism
84. Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: A propensity score matched analysis
    Sandipan Bhattacharjee, Usha Sambamoorthi · 2013 · Parkinsonism & Related Disorders
85. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients with Diabetes?
    Moshe Vardi, Andrew P. Levy · 2012 · Current Diabetes Reports
86. Predicting the Future Burden of Diabetes in Alberta from 2008 to 2035
    Robin S. Lau, Arto Öhinmaa, Jeffrey A. Johnson · 2011 · Canadian Journal of Diabetes
87. Consumer Engagement for Diabetes Technology: Easier Said Than Done
    David Gruber · 2010 · Journal of Diabetes Science and Technology
88. Mechanistic and Clinical Aspects of Renin-Angiotensin-Aldosterone System Blockade in the Prevention of Diabetes Mellitus and Cardiovascular Disease
    Kenneth S. Hershon · 2011 · Endocrine Practice
89. Using the transtheoretical model’s stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting
    Yara I. Arafat, Mohamed Izham Mohamed Ibrahim, Ahmed Awaisu, Stephen Colagiuri, Yaw Owusu, Donald Edward Morisky, M AlHafiz, Ahmed Yousif · 2019 · DARU Journal of Pharmaceutical Sciences
90. Process of care compliance is associated with fewer diabetes complications.
    Felicia J. Bayer, Deron H. Galusha, Martin D. Slade, Isabella M. Chu, Oyebode A. Taiwo, Mark R. Cullen · 2014 · PubMed
91. Increased Cardiovascular Disease, Resource Use, and Costs Before the Clinical Diagnosis of Diabetes in Veterans in the Southeastern U.S.
    Darin E. Olson, Zhu Ming, Qi Long, Diana Barb, JEEHEA SONYA HAW, Mary K. Rhee, Arun V. Mohan, Phyllis I. Watson-Williams, Sandra L. Jackson, Anne M. Tomolo et al. · 2015 · Journal of General Internal Medicine
92. The Effects of Two Bouts of High- and Low-Volume Resistance Exercise on Glucose Tolerance in Normoglycemic Women
    Michael E Reed, Vic Ben‐Ezra, Kyle D. Biggerstaff, David L. Nichols · 2011 · The Journal of Strength and Conditioning Research
93. Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysis
    Lauren J. Lee, Andrew Peng Yu, Scott J. Johnson, Howard G. Birnbaum, Pavel Dimitrov Atanasov, Don P. Buesching, Jeffrey A. Jackson, Jaime A. Davidson · 2009 · Diabetes Research and Clinical Practice
94. Lifestyle Interventions and the Prevention and Treatment of Type 2 Diabetes
    Mary Beth Weber, Jennifer G. Twombly, K.M. Venkat Narayan, Lawrence S. Phillips · 2010 · American Journal of Lifestyle Medicine
95. Influence of a New Diabetes Diagnosis on the Health Behaviors of the Patient’s Partner
    Julie A. Schmittdiel, Solveig Argeseanu Cunningham, Sara R. Adams, Jannie Nielsen, Mohammed Kumail Ali · 2018 · The Annals of Family Medicine
96. Expenditure pattern on diabetes care: A Community based longitudinal study in resettlement colony of East Delhi
    Archana B. Thakur, Tapas Kumar Ray, Manish Kumar Goel · 2017 · Indian Journal of Community Health
97. Renin-Angiotensin-Aldosterone System Blockade in Diabetes: Role of Direct Renin Inhibitors
    Raymond O. Estacio · 2009 · Postgraduate Medicine
98. Medicaid Payment Mechanisms: Impact on Medication Adherence and Health Care Service Utilization in Type 2 Diabetes Enrollees
    Manjiri D. Pawaskar, Steven P. Burch, Eric E. Seiber, Milap Nahata, Ala I. Iaconi, Rajesh Balkrishnan · 2010 · Population Health Management
99. A Simulation of the Comparative Long‐term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
    Sean D. Sullivan, Rafael Alfonso‐Cristancho, Chris Conner, Mette Hammer, Lawrence Blonde · 2009 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
100. Latent class analysis suggests four classes of persons with type 2 diabetes mellitus based on complications and comorbidities in Tianjin, China: a cross-sectional analysis
     Fei Gao, Jiageng Chen, Xiaoqian Liu, Xuying Wang, Haozuo Zhao, Duolan Han, Xiyue Jing, Yuanyuan Liu, Zhuang Cui, Changping Li et al. · 2017 · Endocrine Journal